Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 23, Number 5—May 2017

Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection

Matthew H. CollinsComments to Author , Eileen McGowan, Ramesh Jadi, Ellen Young, Cesar A. Lopez, Ralph S. Baric, Helen M. Lazear, and Aravinda M. de SilvaComments to Author 
Author affiliations: University of North Carolina, Chapel Hill, North Carolina, USA

Main Article

Table 2

Zika virus stains and neutralization in selected serum*

Serum sample ID, IC50
MR766 African Uganda 1947 (21) 2,546 2,898 1,918 3,890
DAK41519 African Senegal 1982 (22) 700 1,186 547 1,203
H/PF/2013 Asian Tahiti 2013 (23) 609 531 516 469
PRVABC59 Asian Puerto Rico 2015 (24) 436 1,606 Not tested Not tested

*IC50, 50% inhibitory concentration; ID, identification.

Main Article

Page created: April 14, 2017
Page updated: April 14, 2017
Page reviewed: April 14, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.